![Joseph Limber](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joseph Limber
Direktor/Vorstandsmitglied bei
XOMA ROYALTY CORPORATION
Vermögen: 1 Mio $ am 31.05.2026
Profil
Joseph M.
Limber is currently Chief Executive Officer at Garda Therapeutics, Inc. and Independent Director at XOMA Royalty Corp.
Formerly, Mr. Limber was President & Chief Executive Officer at Monogram Biosciences, Inc. from 1998 to 2002; President & Chief Executive Officer at Deltagen, Inc. in 2003; President, Chief Executive Officer & Director at Genoptix, Inc. from 2017 to 2018; President & Chief Executive Officer at Gradalis, Inc. from 2013 to 2015; President, Chief Executive Officer & Director at Prometheus Laboratories, Inc. from 2004 to 2013; President, Chief Executive Officer & Director at Secura Bio, Inc.; Chairman at Molecular Insight Pharmaceuticals, Inc. in 2010; Executive Chairman at ImaginAb, Inc. from 2016 to 2017; Director at V.I.
Technologies, Inc.; Independent Non-Executive Director at CombiMatrix Corp.
in 2012; Director at Panacos Pharmaceuticals, Inc. from 2001 to 2009; Executive Vice President at SEQUUS Pharmaceuticals, Inc.; and President & Chief Operating Officer at Praecis Pharmaceuticals, Inc. from 1996 to 1998.
Education includes undergraduate studies at Duquesne University of The Holy Spirit.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 05.06.2026 | 20 000 ( 1,14 % ) | 506 800 $ | 31.05.2026 | |
XOMA ROYALTY CORPORATION 0,08 % | 05.06.2026 | 9 832 ( 0,08 % ) | 410 093 $ | 31.05.2026 |
| 05.06.2026 | 10 000 ( 1,02 % ) | 254 550 $ | 31.05.2026 |
Aktive Positionen von Joseph Limber
| Unternehmen | Position | Beginn |
|---|---|---|
| XOMA ROYALTY CORPORATION | Direktor/Vorstandsmitglied | 13.12.2012 |
Ehemalige bekannte Positionen von Joseph Limber
| Unternehmen | Position | Ende |
|---|---|---|
Genoptix, Inc.
 Genoptix, Inc. Medical SpecialtiesHealth Technology Provides personalized medicine services | Vorstandsvorsitzender | 01.12.2018 |
ImaginAb, Inc.
 ImaginAb, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing radiopharmaceutical and imaging agent products | Vorsitzender | 01.11.2017 |
Gradalis, Inc.
 Gradalis, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer therapies | Vorstandsvorsitzender | 01.04.2015 |
Prometheus Laboratories, Inc.
 Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel pharmaceutical and diagnostic products | Vorstandsvorsitzender | 01.04.2013 |
| COMBIMATRIX CORP | Direktor/Vorstandsmitglied | 09.10.2012 |
Ausbildung von Joseph Limber
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
70
Beziehungen ersten Grades
15
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 15 |
|---|---|
SEQUUS Pharmaceuticals, Inc.
 SEQUUS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Markets lipid-based biopharmaceutical products mainly to treat cancer and infectious diseases | Health Technology |
V.I. Technologies, Inc.
 V.I. Technologies, Inc. BiotechnologyHealth Technology Develops blood products and systems using its proprietary viral inactivation technologies | Health Technology |
Praecis Pharmaceuticals, Inc.
 Praecis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs and therapies for the treatment of cancer | Health Technology |
XOMA Royalty Corp.
 XOMA Royalty Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops antibody therapeutics | Health Technology |
Monogram Biosciences, Inc.
 Monogram Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services for HIV treatment | Commercial Services |
Deltagen, Inc.
 Deltagen, Inc. Miscellaneous Commercial ServicesCommercial Services Provides drug discovery tools and services to the biopharmaceutical industry | Commercial Services |
CombiMatrix Corp.
 CombiMatrix Corp. Medical/Nursing ServicesHealth Services Provides molecular diagnostic services | Health Services |
Genoptix, Inc.
Genoptix, Inc. Medical SpecialtiesHealth Technology Provides personalized medicine services | Health Technology |
Molecular Insight Pharmaceuticals, Inc.
 Molecular Insight Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Develops and commercializes innovative molecular imaging pharmaceuticals | Health Services |
Gradalis, Inc.
Gradalis, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer therapies | Health Technology |
Duquesne University of The Holy Spirit
 Duquesne University of The Holy Spirit Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Prometheus Laboratories, Inc.
Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel pharmaceutical and diagnostic products | Health Technology |
Panacos Pharmaceuticals, Inc.
 Panacos Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes small molecule drugs | Health Technology |
ImaginAb, Inc.
ImaginAb, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing radiopharmaceutical and imaging agent products | Health Technology |
Secura Bio, Inc.
 Secura Bio, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products for oncology therapies | Health Technology |
